Abstract
This chapter describes the two sides of the opioid crisis: the unmet needs of opioids for pain management and the role of prescription and nonprescription opioids (heroin, fentanyl, and new synthetic opioids) in substance use disorders. It draws attention to the unfulfilled United Nations General Assembly (UNGASS) agreements to adopt a public health approach, the United Nations Sustainable Development Goals to strengthen prevention and treatment, the resolution of the World Health Assembly to develop palliative care, and the recommendation by the United National Academies to balance individual and societal needs. It describes illegal and regulated markets and their role in the opioid crisis, pain management and the disparities in the availability of medication between high- and low- and middle-income countries, the world opioid problem, the role of stigma in inadequate access to care and social pain, opioid-assisted treatment, and policy recommendations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
United Nations Office on Drugs and Crime: World Drug Report 2021. Booklet 3 [Internet]. (United Nations publication. Sales No. E.21.XI.8) Vienna; 2021 Jun [cited 2021 Aug 9]. Available from: https://www.unodc.org/unodc/data-and-analysis/wdr2021.html.
World Health Organization. Opioid overdoses [Internet]. 2021 Aug [cited 2021 Aug 15]. Available from: https://www.who.int/news-room/fact-sheets/detail/opioid-overdose.
International Narcotics Control Board. Report 2020 [internet]. United Nations Publication. Sales No.: E.21.XI.3; 2021. (E/INCB/2020/1) Viena; 2021 Mar. [cited 2021 Aug 12] Available from: https://www.incb.org/documents/Publications/AnnualReports/AR2020/Annual_Report/E_INCB_2020_1_eng.pdf.
United Nations Office on Drugs and Crime. Outcome document of the 2016 United Nations General Assembly Special Session of the World Drug Problem. [Internet]. UNGASS 2016, New York; 2016 Apr [cited 2021 Jul 29]. Available from: https://www.unodc.org/documents/postungass2016/outcome/V1603301-E.pdf.
Volkow ND, Poznyak V, Saxena S, Gerra G. UNODC-WHO Informal International Scientific Network. Drug use disorders: impact of a public health rather than a criminal justice approach. World Psychiatry. 2017;16(2):213–4. https://doi.org/10.1002/wps.20428.
United Nations. Sustainable Development Goals [Internet]. 2015 [cited 2021 Aug 12]. Available from: https://www.undp.org/sustainable-development-goals.
World Health Assembly. Strengthening of palliative care as a component of comprehensive care throughout the life course (No. WHA67. 19) [Internet]. 2014 May [cited 2021 Aug 15]. Available from: https://apps.who.int/iris/bitstream/handle/10665/162863/A67_R19-en.pdf?sequence=1&isAllowed=y.
Clark J, Barnes A, Gardiner C. Reframing Global Palliative Care Advocacy for the sustainable development goal era: a qualitative study of the views of International Palliative Care Experts. J Pain Symptom Manag. 2018;56(3):363–70. https://doi.org/10.1016/j.jpainsymman.2018.06.009.
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse. In: Phillips JK, Ford MA, Bonnie RJ, editors. Pain management and the opioid epidemic: balancing societal and individual benefits and risks of prescription opioid use. Washington (D.C.): National Academies Press (U.S.); 2017.
May T, Hough M. Drug markets and distribution systems. Addict Res Theory. 2009;12(6):549–63.
Martínez MM, Ricardo J, Medina-Mora ME, Romero MP, Berenzon S. Los nuevos empresarios: Trayectoria del uso a la venta de drogas en contextos de fiesta. Salud Mental. 2012;35(6):475–81.
Johnson BD. Patterns of drug distribution: implications and issues. Subst Use Misuse. 2003;38(11–13):1789–806. https://doi.org/10.1081/JA-120024241.
Bonnie RJ, Schumacher MA, Clark JD, Kesselheim AS. Pain management and opioid regulation: continuing public health challenges. Am J Public Health. 2019;109(1):31–4. https://doi.org/10.2105/AJPH.2018.304881.
Babor T, Caulkins J, Fischer B, Foxcroft D, Humphreys K, Medina-Mora ME, et al. Drug policy and the public good. 2nd ed. Oxford, UK: Oxford University Press; 2018.
Hosztafi S. A heroin története [The history of heroin]. Acta Pharm Hung. 2001;71(2):233–42.
Quinones S. Dreamland: the true tale of America’s opiate epidemic. 1st ed. New York: Bloomsbury Press; 2016.
Ciccarone D. The triple wave epidemic: supply and demand drivers of the U.S. opioid overdose crisis. Int J Drug Policy. 2019;71:183–8. https://doi.org/10.1016/j.drugpo.2019.01.010.
Volkow ND, Medina-Mora ME, Poznyak V, Saxena S, Gerra G, the UNODC-WHO Informal Science Network. Addressing the opioid crisis globally. World Psychiatry. 2019;18(2):231–2. https://doi.org/10.1002/wps.20633.
United Nations Office on Drugs and Crime: World Drug Report 2020 [Internet]. (United Nations publication. Sales No. E.20.XI.6) Vienna; 2020 Jun [cited 2021 Aug 15] Available from: https://www.casede.org/index.php/biblioteca-casede-2-0/crimen-organizado/narcotrafico-y-drogas/595-world-drug-report-2020/file.
Dudley S, Bonello E, Lopez-Aranda J, Moreno M, Clavel T, Kjestalt B, Restrepo J [Internet] 2019 [cited Aug 2021]. Mexico’s role in the deadly rise fentanyl. Insight Crime & Wilson Center. February 2019. Available from: https://www.wilsoncenter.org/publication/mexicos-role-the-deadly-rise-fentanyl.
RAND Corporation. The future of Fentanyl and other synthetic opioids. [Internet] 2019 [cited Aug 2021]. Library of Congress Cataloging-in-Publication Data is available for this publication. ISBN: 978–1–9774-0338-4 Available from: https://www.rand.org/pubs/research_reports/RR3117.html.
Fleiz C, Arredondo J, Chavez A, Pacheco L, Segovia LA, Villatoro JA, et al. Fentanyl is used in Mexico’s northern border: current challenges for drug health policies. Addiction. 2020;115(4):778–81. https://doi.org/10.1111/add.14934.
Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health. 2009;99(2):221–7. https://doi.org/10.2105/AJPH.2007.131714.
National Institute on Drug Abuse. Overdose Death Rates. [Internet]. 2021 Jan [cited 2021 Aug 11]. Available from: https://www.drugabuse.gov/drug-topics/trends-statistics/overdose-death-rates
Dasgupta N, Mandl KD, Brownstein JS. Breaking the news or fueling the epidemic? Temporal association between news media report volume and opioid-related mortality. PLoS One. 2009;4(11):e7758. https://doi.org/10.1371/journal.pone.0007758.
Zgierska A, Miller M, Rabago D. Patient satisfaction, prescription drug abuse, and potential unintended consequences. JAMA. 2012;307(13):1377–8. https://doi.org/10.1001/jama.2012.419.
Leung PTM, Macdonald EM, Stanbrook MB, Dhalla IA, Juurlink DN. A 1980 letter on the risk of opioid addiction. N Engl J Med. 2017;376(22):2194–5. https://doi.org/10.1056/NEJMc1700150.
Cruz SL, Pérez IP, Carranza CJ. El tratamiento del dolor y los opioides. Ciencia [Internet]. 2020 [cited 2021 Aug 18]; 71(2):52–61. Available from: https://www.amc.edu.mx/revistaciencia/images/revista/71_2/PDF/11_71_2_1228_Opioides-L.pdf.
Humphreys K. Avoiding globalization of the prescription opioid epidemic. Lancet. 2017;390(10093):437–9. https://doi.org/10.1016/S0140-6736(17)31918-9.
Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, Van der Goes DN. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156(4):569–76. https://doi.org/10.1097/01.j.pain.0000460357.01998.f1.
Muhuri PK, Gfroerer JC, Davies MC. Associations of Nonmedical Pain Reliever Use and Initiation of Heroin Use in the United States. CBHSQ Data Review [Internet]. 2013 Aug;1:1–17. [cited 2021 Aug 18]. Available from: https://www.samhsa.gov/data/sites/default/files/DR006/DR006/nonmedical-pain-reliever-use-2013.htm.
Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiat. 2014;71(7):821–6. https://doi.org/10.1001/jamapsychiatry.2014.366.
Carlson RG, Nahhas RW, Martins SS, Daniulaityte R. Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: a natural history study. Drug Alcohol Depend 2016;160:127–34. https://doi.org/10.1016/j.drugalcdep.2015.12.026.
Volkow ND, McLellan AT. Opioid abuse in chronic pain--misconceptions and mitigation strategies. N Engl J Med. 2016;374(13):1253–63. https://doi.org/10.1056/NEJMra1507771.
International Association for the Study of Pain (IASP). Cancer Pain [Internet] Washington, D.C. 2021. [cited 2021 Aug 13]. Available from: https://www.iasp-pain.org/advocacy/global-year/cancer-pain/.
International Narcotics Control Board. Progress in ensuring adequate access to internationally controlled substances for medical and scientific purposes [internet]. United Nations Publication. Sales No.: E.19.XI.4; 2019. (E/INCB/2018/Supp.1) Vienna. 2019 Mar [cited 2021 Aug 12]. Available from: file:///C:/Users/Equipo21/Downloads/Supplement_E_ebook.pdf.
International Association for Hospice and Palliative Care (IAHPC). Global data platform to calculate SHS and palliative care need [Internet]. Houston: 2021. [cited 2021 Aug 13]. Available from: https://hospicecare.com/what-we-do/resources/global-data-platform-to-calculate-shs-and-palliative-care-need/.
Knaul FM, Farmer PE, Krakauer EL, De Lima L, Bhadelia A, Kwete XJ, et al. Alleviating the access abyss in palliative care and pain relief-an imperative of universal health coverage: the Lancet Commission report. Lancet. 2018;391(10128):1391–454. https://doi.org/10.1016/S0140-6736(17)32513-8.
McGuire DB. Comprehensive and multidimensional assessment and measurement of pain. J Pain Symptom Manag. 1992;7(5):312–9. https://doi.org/10.1016/0885-3924(92)90064-o.
Hui D, Bruera E. A personalized approach to assessing and managing pain in patients with cancer. J Clin Oncol. 2014;32(16):1640–6. https://doi.org/10.1200/JCO.2013.52.2508.
World Health Organization (WHO). Cancer pain relief. World Health Organization [Internet]. Geneva, 1986 [cited 2021 Aug 14] Available from: https://apps.who.int/iris/handle/10665/43944.
Breivik H, Collet B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life and treatment. Eur J Pain. 2006;10(4):287–333. https://doi.org/10.1016/j.ejpain.2005.06.009.
Atluri S, Akbik H, Sudarshan G. Prevention of opioid abuse in chronic non-cancer pain: an algorithmic, evidence based approach. Pain Physician. 2012;15:ES177–89.
Trescot AM, Boswell MV, Atluri SL, Hansen HC, Deer TR, Abdi S, et al. Opioid guidelines in the management of chronic non-cancer pain. Pain Physician. 2006;9(1):1–39.
Sullivan MD, Von Korff M, Banta-Green C, Merrill JO, Saunders K. Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain. Pain. 2010;149(2):345–53. https://doi.org/10.1016/j.pain.2010.02.037.
Gómez MC, Zertuche T, Bruera E. Chemical compensation and opioid addiction: evidence, risk assessment and management in palliative care patients. Med Paliat [Internet]. 2018 [cited 2021 Aug 16]; 25(4):281–90. Available from: https://www.medicinapaliativa.es/(X(1)S(vd4mms1rvvhn2b2tlkk0du5m))/Documentos/ArticulosNew/REV.pdf
Kwon JH, Hui D, Bruera E. A pilot study to define chemical coping in cancer patients using the Delphi Method. J Palliat Med. 2015;18(8):703–6. https://doi.org/10.1089/jpm.2014.0446.
Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall BD, et al. Global patterns of opioid use and dependence: population harms, interventions, and future action. Lancet. 2019;394(10208):1560–79. https://doi.org/10.1016/S0140-6736(19)32229-9.
Volkow ND. Prescription drug abuse. National Institute on Drug Abuse [Internet]. 2010 Sep [cited 2021 Aug 18]. Available from: https://archives.drugabuse.gov/testimonies/2010/prescription-drug-abuse.
Volkow ND. Stigma and the toll of addiction. N Engl J Med [Internet]. 2020 [cited 2021 Aug 18]; 382(14):1289–90. Available from: https://www.nejm.org/doi/full/10.1056/NEJMp1917360.
Fleiz C, Villatoro JA, Dominguez M, Bustos M, Medina-Mora ME. Opioid crisis along Mexico’s Northern border: treatment needs Mexican opioid crisis. Arch Med Res. 2019;50(8):527–34. https://doi.org/10.1016/j.arcmed.2019.12.013.
United Nations Development Program, World Health Organization, United Nations Program on HIV/AIDS, United Nations Human Rights. International Guidelines on Human Rights and Drug Policy. [Internet]. 2019 [cited Aug 2021]. Germany March 2019. Available from: https://www.humanrights-drugpolicy.org/
Harm Reduction International. The Global State of Harm Reduction 2020 [Internet]. 2020 [cited Aug 2021]. 7th ed. London: Harm Reduction International. Available from: https://www.hri.global/global-state-of-harm-reduction-2020.
International Narcotics Control Board. Narcotic Drugs 2020 [Internet]. United Nations Publication. Sales No.: T.21.XI.2 (E/INCB/2020/2) Vienna, 2021 [cited 2021 Aug 10]. Available from: https://www.incb.org/documents/Narcotic-Drugs/Technical-Publications/2020/Narcotic_Drugs_Technical_publication_2020.pdf.
Jalal H, Buchanich JM, Sinclair DR, Roberts MS, Burke DS. Age and generational patterns of overdose death risk from opioids and other drugs. Nat Med. 2020;26(5):699–704. https://doi.org/10.1038/s41591-020-0855-y.
Hall W, Degenhardt L, Hickman M. Generational trends in U.S. opioid-overdose deaths. Nat Med. 2020;26(5):651–2. https://doi.org/10.1038/s41591-020-0875-7.
Rafful C, Medina-Mora ME, González P, Jenkins JH, Rangel MG, Strathdee SA, Davidson PJ. “Somebody is Gonna be hurt”: involuntary drug treatment in Mexico. Med Anthropol. 2020;39(2):139–52. https://doi.org/10.1080/01459740.2019.1609470.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Medina-Mora, M.E., Martín-del-Campo, R., Salazar-Trujillo, N.V., Dávila, H., Fleiz, C., Villatoro, J. (2022). The Two Sides of Opioid Use: Unmet Needs of Opioids for Pain Management and the Role of Opioids in Substance Use Disorders. In: Cruz, S.L. (eds) Opioids. Springer, Cham. https://doi.org/10.1007/978-3-031-09936-6_2
Download citation
DOI: https://doi.org/10.1007/978-3-031-09936-6_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-09935-9
Online ISBN: 978-3-031-09936-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)